Topical dimethyl sulfoxide inhibits corneal neovascularization and stimulates corneal repair in rabbits following acid burn

References

• Altan S, Ogurtan Z (2017) Dimethyl sulfoxide but not indomethacin is efficient for healing of hydrofluoric acid eye burn. Burns 43: 232–244.
   PubMed Web of Science ®Google Scholar
• Amano S, Rohan R, Kuroki M, Tolentino M, Adamis AP (1998) Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest. Ophthal. Vis. Sci. 39: 18–22.
   PubMed Web of Science ®Google Scholar
• Atley K, Ridyard E (2015) Treatment of hydrofluoric acid exposure to the eye. Int. J. Ophthal. 8: 157–161.
   PubMed Web of Science ®Google Scholar
• Balicki I (2008) Application of dimethyl sulfoxide and cyclosporine in long-term treatment of chronic superficial keratitis in dogs. Proceeding book ECVO meeting. Vet. Ophthal. 12:61–70.
   Google Scholar
• Balicki I (2012) Clinical study on the application of tacrolimus and DMSO in the treatment of chronic superficial keratitis in dogs. Pol. J. Vet. Sci. 15: 667–676.
   PubMed Web of Science ®Google Scholar
• Bock F, Onderka J, Dietrich T, Bachmann B, Kruse FE, Paschke M, Zahn G, Cursiefen C (2007) Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis. Invest. Ophthal. Vis. Sci. 48: 2545–2552.
   PubMed Web of Science ®Google Scholar
• Chang JH, Gabison EE, Kato T, Azar DT (2001) Corneal neovascularization. Curr. Opin. Ophthal. 12: 242–249.
   PubMed Web of Science ®Google Scholar
• Chang JH, Garg NK, Lunde E, Han KY, Jain S, Azar DT (2012) Corneal neovascularization: an anti-VEGF therapy review. Surv. Ophthal. 57: 415–429.
   PubMed Web of Science ®Google Scholar
• Chetty S, Pagliuca FW, Honore C, Kweudjeu A, Rezania A, Melton DA (2013) A simple tool to improve pluripotent stem cell differentiation. Nat. Methods 10: 553–556.
   PubMed Web of Science ®Google Scholar
• Comptour A, Rouzaire M, Belville C, Bonnin N, Daniel E, Chiambaretta F, Blanchon L, Sapin V (2016). Lysyl oxidase-like 4 involvement in retinoic acid epithelial wound healing. Sci. Rep. doi: 10.1038/srep32688.
   PubMed Web of Science ®Google Scholar
• Cursiefen C, Rummelt C, Küchle M (2000) Immunohistochemical localization of vascular endothelial growth factor, transforming growth factor α, and transforming growth factor β1 in human corneas with neovascularization. Cornea 19: 526–533.
   PubMed Web of Science ®Google Scholar
• Duan L, Yang G, Zhang R, Feng L, Xu C (2012) Advancement in the research on vascular endothelial growth inhibitor (VEGI). Targ. Oncol. 7: 87–90.
   PubMed Web of Science ®Google Scholar
• Gan L, Fagerholm P, Palmblad J (2004) Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in the regulation of corneal neovascularization and wound healing. Acta Ophthal. Scand. 82: 557–563.
   PubMedGoogle Scholar
• Kim JS, Choi JS, Chung SK (2010) The effect of curcumin on corneal neovascularization in rabbit eyes. Curr. Eye Res. 35: 274–280.
   PubMed Web of Science ®Google Scholar
• Koay P (1996). The emerging roles of topical non-steroidal anti-inflammatory agents in ophthalmology. Br. J. Ophthal. 80: 480–485.
   PubMed Web of Science ®Google Scholar
• Laria C, Alio JL, Ruiz-Moreno JM (1997) Combined non-steroidal therapy in experimental corneal injury. Ophthal. Res. 29: 145–53.
   PubMed Web of Science ®Google Scholar
• Lejbkowicz F, Goldberg-Cohen I, Levy AP (2005). New horizons for VEGF. Is there a role for nuclear localization? Acta Histochem. 106: 405–441.
   PubMed Web of Science ®Google Scholar
• Metheny-Barlowa LJ, Li LY (2006). Vascular endothelial growth inhibitor (VEGF) an endogenous negative regulator of angiogenesis. Sem. Ophthal. 21: 49–58.
   PubMedGoogle Scholar
• Ogaki S, Morooka M, Otera K, Kume S (2015) A cost-effective system for differentiation of intestinal epithelium from human induced pluripotent stem cells. Sci. Rep UK 5: 17297 DOI: 10.1038/srep17297.
   PubMed Web of Science ®Google Scholar
• Onder HI, Erdurmus M, Bucak YY, Simavli H, Oktay M, Kukner AS (2014) Inhibitory effects of regorafenib, a multiple tyrosine kinase inhibitor, on corneal neovascularization. Int. J. Ophthal. 7: 220–225.
   PubMed Web of Science ®Google Scholar
• Ozdemir O, Altintas O, Altintas L, Ozkan B, Akdag C, Yüksel N (2014) Comparison of the effects of subconjunctival and topical anti-VEGF therapy (bevacizumab) on experimental corneal neovascularization. Arq. Bras. Oftal. 77: 209–213.
   PubMed Web of Science ®Google Scholar
• Prabhat KP, Sanaz AL (2007) Ocular emergencies. Am. Fam. Phys. 76: 829–836.
   PubMed Web of Science ®Google Scholar
• Sağsöz H, Liman N, Küçükaslan I, Saruhan BG (2013) Immunolocalization of vascular endothelial growth factor, its receptors (flt1/fms, flk1/KDR, flt4) and vascular endothelial growth inhibitor in the bitch uterus during the sexual cycle. Anim. Reprod. Sci. 140: 241– 254.
   PubMed Web of Science ®Google Scholar
• Shakiba Y, Mostafaie A (2007) Inhibition of corneal neovascularization with a nutrient mixture containing lysine, proline, ascorbic acid, and green tea extract. Arch. Med. Res. 38: 789–791.
   PubMed Web of Science ®Google Scholar
• Shi W, Ming C, Liu J, Wang T, Gao H (2011) Features of corneal neovascularization and lymphangiogenesis induced by different etiological factors in mice. Graefes Arch. Clin. Exp. Ophthal. 249: 55–67.
   PubMed Web of Science ®Google Scholar
• Skrypuch OW, Tokarewicz AC, Willis NR (1987). Effects of dimethyl sulfoxide on model of corneal alkali injury. Can. J. Ophthal. 22: 17–20.
   PubMed Web of Science ®Google Scholar
• Toczołowski J, Wolski T, Klamut-Sory K (1992). Effect of drugs inhibiting the formation of hydroxide radicals on healing of experimental corneal ulcer. Klin. Oczna. 94: 83–85.
   PubMedGoogle Scholar
• Totan Y, Aydın E, Çekiç O, Dağlıoğlu MC, Borazan M, Dağlıoğlu K, Gültek A (2001) Effect of caffeic acid phenethyl ester on corneal neovascularization in rats. Curr. Eye Res. 23: 291–229.
   PubMed Web of Science ®Google Scholar
• van Setten GB (1997) Vascular endothelial growth factor (VEGF) in normal human corneal epithelium: detection and physiological importance. Acta Ophthal. Scand. 75: 649–652.
   PubMedGoogle Scholar
• Wagoner MD (1997) Chemical injuries of the eye. Current concepts in pathophysiology and therapy. Surv. Ophthal. 41: 275–313.
   PubMed Web of Science ®Google Scholar
• Wang H, Wang B (2010) Inhibition of corneal neovascularization by vascular endothelial growth inhibitor gene. Int. J. Ophthal. 3: 295–298.
   PubMed Web of Science ®Google Scholar
• Yan J, Zeng Y, Jiang J, Zhou J, Yin Z, Wang Z, Zhu P (2007) The expression patterns of vascular endothelial growth factor and thrombospondin 2 after corneal alkali burn. Coll. Surf. B Biointerf. 60: 105–109.
   PubMed Web of Science ®Google Scholar
• Yue TL, Ni J, Romanic AM, Gu JL, Keller P, Wang C, Kumar S, Yu GL, Hart TK, Wang X, Xia Z, DeWolf WE Jr, Feuerstein GZ (1999) TL1, a novel tumor necrosis factor-like cytokine, induces apoptosis in endothelial cells. Involvement of activation of stress protein kinases (stress activated protein kinase and p38 mitogen-activated protein kinase) and caspase-3-like protease. J. Biol. Chem. 274: 1479–1486.
   PubMed Web of Science ®Google Scholar
• Zhang N, Sanders AJ, Ye L, Kynaston HG, Jiang WG (2010) Expression of vascular endothelial growth inhibitor (VEGI) in human urothelial cancer of the bladder and its effects on the adhesion and migration of bladder cancer cells in vitro. Anticancer Res. 30: 87–95.
   PubMed Web of Science ®Google Scholar
• Zhang YX, Zhang MC (2008) Inhibitory effects of pioglitazone on alkaline burn induced corneal neovascularization in rats. Int. J. Ophthal. 1: 99–103.
   Web of Science ®Google Scholar
• Zhang Z, Ma JX, Gao G, Li C, Luo L, Zhang M, Yang W, Jiang A, Kuang W, Xu L, Chen J, Liu Z (2005) Plasminogen kringle 5 inhibits alkali-burn–induced corneal neovascularization. Invest. Ophthal. Vis. Sci. 46: 4062–4071.
   PubMed Web of Science ®Google Scholar